Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Director/PDMR Shareholding

4 Jan 2022 09:27

RNS Number : 3367X
IQ-AI Limited
04 January 2022
 

4 January 2022

IQ-AI Ltd

("IQ-AI" or the "Company")

 

Director/PDMR Shareholding

 

IQ-AI announces that Michael Schmainda, Director of IQAI and CEO of Imaging Biometrics, has been granted an option to subscribe for 5,969,792 ordinary shares of 1p each in the Company ("Ordinary Shares") at an exercise price of 5.88p per share. The option will vest on 15 December 2024.

 

Michael Schmainda is currently interested in 9,108,400 Ordinary Shares, representing 4.99 per cent. of the voting rights of the Company.

 

The Directors of the Company accept responsibility for the contents of this announcement

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Brett Skelly/Vinod Kaushal

Tel: 020 7469 0930

 

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Schmainda

2

Reason for the notification

a)

Position/status

Director of the Company

b)

Initial notification /Amendment

 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Limited

b)

LEI

213800SPW48XRJS2QH57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

 

 

 

 

ISIN: JE00BD4H0R42

b)

Nature of the transaction

Grant of Option

 

c)

Price(s) and volume(s)

5,969,792 ordinary shares at 5.88p per share

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

N/A (single transaction)

 

e)

Date of the transaction

15 December 2021

 

f)

Place of the transaction

N/A

 

 

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEANFLEADAEEA
Date   Source Headline
16th Jun 20177:00 amRNSReadmission to the London Stock Exchange
15th Jun 20171:42 pmRNSResult of Annual General Meeting & General Meeting
19th May 20177:00 amRNSProspectus, Placing & Expected Readmission
28th Apr 20173:12 pmRNSFinal Results
27th Feb 201711:51 amRNSHolding(s) in Company
20th Jan 20171:30 pmRNSAppointment of Non-Executive Director
26th Aug 201612:06 pmRNSHalf-year Report
30th Jun 201612:58 pmRNSProposed Acquisition and Suspension of Listing
31st May 20161:33 pmRNSHolding(s) in Company
27th May 201611:39 amRNSResult of AGM
5th May 20164:15 pmRNSHolding(s) in Company
4th May 20167:00 amRNSNotice of AGM
20th Apr 20167:00 amRNSHolding(s) in Company
20th Apr 20167:00 amRNSFinal Results
5th Apr 201610:48 amRNSStatement re Update
20th Nov 20157:00 amRNSBoard changes, corporate update, issue of CLN
21st Oct 20157:00 amRNSAppointment of Financial Adviser and Broker
25th Aug 20153:29 pmRNSHalf Yearly Report
16th Jul 201511:17 amRNSHolding(s) in Company
16th Jul 201511:15 amRNSHolding(s) in Company
13th Jul 20152:57 pmRNSConversion of Convertible Loan Notes
29th May 20154:21 pmRNSResult of AGM
1st May 201511:28 amRNSNotice of AGM and Transfer of CLN to Director-Rep
30th Apr 20156:28 pmRNSNotice of AGM and Transfer of CLN to Director
17th Apr 201511:00 amRNSPreliminary Results
11th Mar 20152:16 pmRNSResult of EGM
13th Feb 20157:00 amRNSBoard Changes and Notice of EGM
31st Dec 20147:00 amRNSUpdate
7th Nov 20143:24 pmRNSSale of Retreat Farm
27th Aug 20147:00 amRNSInterim Results Announcement
11th Jun 201411:42 amRNSResult of AGM
29th Apr 20143:33 pmRNSAnnual Report and Results Announcement
8th Apr 20147:00 amRNSDirectorate Change
9th Jan 201411:30 amRNSDirectorate Change
15th Nov 20137:00 amRNSInterim Management Statement
28th Aug 20137:00 amRNSHalf Yearly Report
13th Jun 20137:00 amRNSResult of AGM
26th Apr 20137:00 amRNSAnnual Report and Results Announcement
25th Apr 20134:59 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jan 20131:31 pmRNSRefinancing of Flowers Direct and Board changes
19th Nov 20127:00 amRNSTrading Update
31st Aug 20127:00 amRNSHalf Yearly Report
1st Aug 20127:00 amRNSClosure of Growing and Live Dispatch Business
9th Jul 20127:00 amRNSDisposal
13th Jun 201210:25 amRNSResult of AGM
6th Jun 20128:05 amRNSTransfer to Standard Listing
28th May 20123:03 pmRNSMerger Update
22nd May 201211:15 amRNSInterim Management Statement
16th May 20122:00 pmRNSMerger Update
4th May 201210:27 amRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.